# Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

> **NCT01097304** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 36 (actual)

## Conditions studied

- Barrett Esophagus
- Esophageal Carcinoma

## Interventions

- **DRUG:** Ursodiol
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT01097304
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097304, "Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01097304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*